The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its ...

Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Hold rating on Cassava Sciences (SAVA – Research Report) today. The company’s shares ...

Cassava Sciences SAVA, a clinical-stage biotech focusing on developing novel products to detect and treat neurodegenerative diseases, such as Alzheimer’s disease (AD), is expected to report ...

The Federal Government has pledged its support for Agbeyewa Farms investment in cassava farming and agro-processing, ...

Explore Cassava Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SAVA. Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of Cassava Sciences, Inc. (NASDAQ: SAVA) climbed 7% following the company's announcement of securing an exclusive license to a method of treatment patent f ...

Outer Richmond in 2012, first making a name for itself with its Japanese breakfast before moving to North Beach and pivoting ...